DocSym
β
Searchsearch
Search
(T44.2) Poisoning: ganglionic blocking drugs, not elsewhere classified
More details coming soon
140 805 in individuals diagnosis poisoning: ganglionic blocking drugs, not elsewhere classified confirmed
Diagnosis poisoning: ganglionic blocking drugs, not elsewhere classified is diagnosed Women are 11.20% more likely than Men
62 514
Men receive the diagnosis poisoning: ganglionic blocking drugs, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
78 291
Women receive the diagnosis poisoning: ganglionic blocking drugs, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease poisoning: ganglionic blocking drugs, not elsewhere classified - Men and Women aged 0-5
In Men diagnosis is most often set at age 0-89
Less common in men the disease occurs at Age 90-95+Less common in women the disease occurs at Age 95+
In Women diagnosis is most often set at age 0-94
Disease Features poisoning: ganglionic blocking drugs, not elsewhere classified
Absence or low individual and public risk
Poisoning: ganglionic blocking drugs, not elsewhere classified - what does this mean
Ganglionic blocking drugs, not elsewhere classified, are a type of poisoning that occurs when drugs that block nerve signals to the autonomic ganglia are taken. this can result in a wide range of symptoms, including slowed heart rate, slowed breathing, low blood pressure, and dizziness.
What happens during the disease - poisoning: ganglionic blocking drugs, not elsewhere classified
The pathogenesis of poisoning due to ganglionic blocking drugs is caused by a disruption of the normal neurotransmission in the autonomic nervous system. these drugs act by blocking the release of neurotransmitters in the autonomic ganglia, resulting in a decrease in the transmission of nerve impulses. this disruption of the normal functioning of the autonomic nervous system can lead to a variety of symptoms, including hypotension, bradycardia, respiratory depression, and paralysis.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Urine tests
- Imaging tests (e.g. X-ray, CT scan, MRI)
- Electrocardiogram (ECG)
- Electroencephalogram (EEG)
- Toxicology screening
- Liver function tests
- Neurological tests
- Psychological tests
- Brain imaging tests (e.g. PET scan, SPECT scan)
Treatment and Medical Assistance
Main goal of the treatment: Reduce symptoms of poisoning caused by ganglionic blocking drugs.
- Administer an antidote to counteract the effects of the poison
- Provide supportive care, such as fluids and oxygen, to maintain vital functions
- Monitor vital signs, such as heart rate and blood pressure, and provide supportive care accordingly
- Administer medications, such as anticonvulsants, to control seizures
- Provide respiratory support, such as mechanical ventilation, if necessary
- Monitor for and treat any complications, such as arrhythmias or respiratory failure
- Provide psychological support to reduce stress and anxiety
6 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Poisoning: ganglionic blocking drugs, not elsewhere classified - Prevention
The best way to prevent poisoning from ganglionic blocking drugs is to avoid taking them without a doctor's prescription and to be aware of any potential side effects. additionally, it is important to keep these drugs out of the reach of children and to follow all instructions for proper storage.